Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 38777 San Mateo, CA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$771,101
-$7,625,991 QoQ
Shares Held
42,345
-97.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 183 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. CGEM ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,771,839 $1,728,352,485
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,347,253 $1,662,680,977
3 ASND
Ascendis Pharma A/S
 1,862,503 $496,766,798
4 JAZZ
Jazz Pharmaceuticals plc
 2,040,250 $491,639,040
5 RVMD
Revolution Medicines, Inc.
 1,488,394 $278,746,426
6 INSM
INSMED Inc
 2,273,222 $242,370,927
7 LGND
Ligand Pharmaceuticals Inc
 752,044 $237,713,585
8 ARGX
Argenx SE
 224,930 $208,683,303

All Filings in CGEM

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $771,101 42,345
2025-09-30 $8,397,092 1,416,036
2025-06-30 $16,778,044 2,228,160
2025-03-31 $16,803,589 2,219,761
2024-12-31 $26,792,455 2,199,709
2024-09-30 $36,681,725 2,191,262
2024-06-30 $42,625,625 2,444,130
2024-03-31 $45,952,822 2,696,762
2023-12-31 $33,436,242 3,281,280
2023-09-30 $26,161,513 2,890,775
2023-06-30 $25,114,764 2,334,086
2023-03-31 $8,072,881 789,138
2022-12-31 $8,251,429 782,126
2022-09-30 $10,066,507 785,219
2022-06-30 $9,987,831 779,082
2022-03-31 $8,144,403 777,880
2021-12-31 $11,951,059 774,534
2021-09-30 $17,523,483 776,406
2021-06-30 $20,020,573 777,498
2021-03-31 $20,347,794 488,308